What is the current annual SG&A of NVS?

As of today, NVS annual SG&A is $0.00

What is 1-year change in NVS annual SG&A?

NVS annual SG&A is down -100.00% year-over-year

What is 3-year change in NVS annual SG&A?

NVS annual SG&A is down -100.00% over the past 3 years

How far is NVS annual SG&A from its all-time high?

NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011

How does NVS annual SG&A rank versus sector peers?

NVS annual SG&A is higher than 71.39% of companies in Healthcare sector

When is NVS next annual earnings release?

The next annual earnings release for NVS is on February 3, 2027

What is the current quarterly SG&A of NVS?

As of today, NVS quarterly SG&A is $3.06B

What is NVS quarterly SG&A most recent change?

NVS quarterly SG&A was down -5.54% on September 30, 2026

What is 1-year change in NVS quarterly SG&A?

NVS quarterly SG&A is down -7.17% year-over-year

How far is NVS quarterly SG&A from its all-time high?

NVS quarterly SG&A is currently -39.69% below its historical high of $5.08B set on December 31, 2010

How does NVS quarterly SG&A rank versus sector peers?

NVS quarterly SG&A is higher than 99.25% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

What is the current TTM SG&A of NVS?

As of today, NVS TTM SG&A is $158.17B

What is NVS TTM SG&A most recent change?

NVS TTM SG&A was down -4.22% on September 30, 2026

What is 1-year change in NVS TTM SG&A?

NVS TTM SG&A is up +1086.19% year-over-year

How does NVS TTM SG&A rank versus sector peers?

NVS TTM SG&A is higher than 99.18% of companies in Healthcare sector

When is NVS next earnings release?

The next earnings release for NVS is on February 3, 2027

Novartis AG (NVS) SG&A History & Chart Since 1993

Annual SG&A

$0.00$12.56B-100.00%

December 31, 2025

Summary

Current Value: As of today, NVS annual SG&A is $0.00, down -100.00% on December 31, 2025
Historical Performance: NVS annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
All-Time High Comparison: NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011
Sector Comparison: NVS annual SG&A is higher than 71.39% of companies in Healthcare sector

SG&A Chart

beforeafter

Performance

NVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 25	$0.00	-100.0%	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Sep 30, 26	$3.06B	-7.2%	-0.9%	-15.3%	-35.4%
TTM SG&A	Sep 30, 26	$158.17B	+1086.2%	+1190.5%	+966.9%	+719.5%
Price	Nov 6, 26	$162.55	+28.4%	+73.9%	+94.3%	+223.4%
Annual Operating Expenses	Dec 31, 25	$24.57B	+11.4%	+20.1%	+8.2%	-7.2%
Annual Operating Profit	Dec 31, 25	$16.47B	+6.8%	+58.6%	+52.2%	+77.5%
Annual D&A	Dec 31, 25	$5.35B	-11.8%	-20.3%	+4.7%	+116.0%
Annual Revenue	Dec 31, 25	$54.81B	+9.0%	+29.6%	+12.0%	+9.2%

SG&A Highs

NVS Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$12.56B	Dec 31, 24	-100.0%
5Y	$14.89B	Dec 31, 21	-100.0%
All	$17.86B	Dec 31, 11	-100.0%

SG&A Lows

NVS Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$0.00	Dec 31, 25	N/A
5Y	$0.00	Dec 31, 25	N/A
All	$0.00	Dec 31, 25	N/A

SG&A History

Year	Value	Change
2025	$0.00	-100.0%
2024	$12.56B	+0.3%
2023	$12.52B	+2.7%
2022	$12.19B	-18.1%
2021	$14.89B	+4.9%
2020	$14.20B	-1.2%
2019	$14.37B	+4.8%
2018	$13.72B	-8.5%
2017	$15.00B	+5.7%
2016	$14.19B	-0.4%
2015	$14.25B	-5.0%
2014	$14.99B	-1.6%
2013	$15.24B	-11.9%
2012	$17.29B	-3.2%
2011	$17.86B	+14.0%
2010	$15.67B	+9.8%
2009	$14.28B	+1.4%

Year	Value	Change
2008	$14.08B	+6.2%
2007	$13.26B	+10.7%
2006	$11.97B	+8.1%
2005	$11.08B	+7.0%
2004	$10.35B	+11.9%
2003	$9.26B	+14.6%
2002	$8.08B	+7.5%
2001	$7.51B	-2.5%
2000	$7.71B	+4.9%
1999	$7.35B	+0.8%
1998	$7.29B	-2.6%
1997	$7.48B	-21.9%
1996	$9.58B	-1.4%
1995	$9.72B	+4.7%
1994	$9.29B	+2.9%
1993	$9.02B	-

FAQ

What is the current annual SG&A of NVS?: As of today, NVS annual SG&A is $0.00
What is 1-year change in NVS annual SG&A?: NVS annual SG&A is down -100.00% year-over-year
What is 3-year change in NVS annual SG&A?: NVS annual SG&A is down -100.00% over the past 3 years
How far is NVS annual SG&A from its all-time high?: NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011
How does NVS annual SG&A rank versus sector peers?: NVS annual SG&A is higher than 71.39% of companies in Healthcare sector
When is NVS next annual earnings release?: The next annual earnings release for NVS is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Quarterly SG&A

$3.06B$179.60M-5.54%

September 30, 2026

Summary

Current Value: As of today, NVS quarterly SG&A is $3.06B, down -5.54% on September 30, 2026
Historical Performance: NVS quarterly SG&A is down -7.17% year-over-year, down -0.89% over the past 3 years
All-Time High Comparison: NVS quarterly SG&A is currently -39.69% below its historical high of $5.08B set on December 31, 2010
3-Year Low Comparison: NVS quarterly SG&A is +7.87% above its 3-year low of $2.84B reached on March 31, 2024
Sector Comparison: NVS quarterly SG&A is higher than 99.25% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Sep 30, 26	$3.06B	-5.5%	-7.2%	-0.9%	-15.3%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
TTM SG&A	Sep 30, 26	$158.17B	+1104.1%	+1086.2%	+1190.5%	+966.9%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
Quarterly Operating Expenses	Sep 30, 26	$6.03B	+0.5%	-2.0%	+18.4%	+3.1%
Quarterly Operating Profit	Sep 30, 26	$4.85B	+2.5%	+15.7%	+42.5%	+48.9%
Quarterly D&A	Sep 30, 26	$3.57B	+155.2%	+144.1%	+14.9%	+146.0%
Quarterly Revenue	Sep 30, 26	$14.44B	+0.1%	+4.0%	+22.5%	+10.8%

Quarterly SG&A Highs

NVS Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$3.44B	Dec 31, 25	-10.9%
3Y	$3.50B	Jun 30, 25	-12.4%
5Y	$3.99B	Dec 31, 21	-23.1%
All	$5.08B	Dec 31, 10	-39.7%

Quarterly SG&A Lows

NVS Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$3.06B	Sep 30, 26	at low
3Y	$2.84B	Mar 31, 24	+7.9%
5Y	$2.84B	Mar 31, 24	+7.9%
All	$0.00	Dec 31, 00	N/A

Quarterly SG&A History

Month	Value	Change
Sep 2026	$3.06B	-5.5%
Jun 2026	$3.24B	+2.9%
Mar 2026	$3.15B	-8.4%
Dec 2025	$3.44B	+4.2%
Sep 2025	$3.30B	-5.6%
Jun 2025	$3.50B	+14.3%
Mar 2025	$3.06B	-12.0%
Dec 2024	$3.48B	+9.7%
Sep 2024	$3.17B	+2.5%
Jun 2024	$3.09B	+8.8%
Mar 2024	$2.84B	-17.5%
Dec 2023	$3.44B	+11.4%
Sep 2023	$3.09B	0.0%
Jun 2023	$3.09B	+6.9%
Mar 2023	$2.89B	-9.2%
Dec 2022	$3.18B	+8.4%
Sep 2022	$2.94B	-18.0%
Jun 2022	$3.58B	+2.0%
Mar 2022	$3.51B	-11.9%
Dec 2021	$3.99B	+10.1%
Sep 2021	$3.62B	-3.6%
Jun 2021	$3.75B	+6.4%
Mar 2021	$3.53B	-10.1%
Dec 2020	$3.92B	+14.8%
Sep 2020	$3.42B	+1.5%
Jun 2020	$3.37B	-3.4%
Mar 2020	$3.49B	-10.7%
Dec 2019	$3.91B	+10.0%
Sep 2019	$3.55B	-1.0%
Jun 2019	$3.59B	+7.7%
Mar 2019	$3.33B	-9.4%
Dec 2018	$3.68B	+12.8%
Sep 2018	$3.26B	-6.7%
Jun 2018	$3.50B	+6.4%
Mar 2018	$3.28B	-18.7%
Dec 2017	$4.04B	+9.9%
Sep 2017	$3.68B	-3.4%
Jun 2017	$3.81B	+9.6%
Mar 2017	$3.47B	-9.5%
Dec 2016	$3.84B	+12.9%
Sep 2016	$3.40B	-6.8%
Jun 2016	$3.65B	+10.4%
Mar 2016	$3.31B	-14.9%
Dec 2015	$3.89B	+12.2%
Sep 2015	$3.46B	-4.3%
Jun 2015	$3.62B	+10.2%
Mar 2015	$3.28B	-17.2%
Dec 2014	$3.97B	+11.2%
Sep 2014	$3.57B	-8.6%
Jun 2014	$3.90B	-10.0%
Mar 2014	$4.33B	+4.5%
Dec 2013	$4.15B	+12.8%
Sep 2013	$3.67B	-2.9%

Month	Value	Change
Jun 2013	$3.78B	-10.7%
Mar 2013	$4.24B	-8.6%
Dec 2012	$4.64B	+17.9%
Sep 2012	$3.93B	-5.2%
Jun 2012	$4.15B	+3.9%
Mar 2012	$3.99B	-13.5%
Dec 2011	$4.62B	-2.6%
Sep 2011	$4.74B	-5.2%
Jun 2011	$5.00B	+11.8%
Mar 2011	$4.48B	-11.9%
Dec 2010	$5.08B	+33.6%
Sep 2010	$3.80B	+7.9%
Jun 2010	$3.52B	-1.7%
Mar 2010	$3.58B	-18.8%
Dec 2009	$4.41B	+30.6%
Sep 2009	$3.38B	-4.4%
Jun 2009	$3.53B	+9.6%
Mar 2009	$3.23B	-12.4%
Dec 2008	$3.68B	+6.1%
Sep 2008	$3.47B	-5.5%
Jun 2008	$3.68B	+13.5%
Mar 2008	$3.24B	-12.0%
Dec 2007	$3.68B	+15.7%
Sep 2007	$3.18B	-4.1%
Jun 2007	$3.32B	+4.9%
Mar 2007	$3.16B	-9.5%
Dec 2006	$3.50B	-10.0%
Sep 2006	$3.88B	+32.6%
Jun 2006	$2.93B	+8.5%
Mar 2006	$2.70B	>+9,900.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	0.0%
Mar 2001	$0.00	0.0%
Dec 2000	$0.00	-100.0%
Jun 2000	$1.65B	-

FAQ

What is the current quarterly SG&A of NVS?: As of today, NVS quarterly SG&A is $3.06B
What is NVS quarterly SG&A most recent change?: NVS quarterly SG&A was down -5.54% on September 30, 2026
What is 1-year change in NVS quarterly SG&A?: NVS quarterly SG&A is down -7.17% year-over-year
How far is NVS quarterly SG&A from its all-time high?: NVS quarterly SG&A is currently -39.69% below its historical high of $5.08B set on December 31, 2010
How does NVS quarterly SG&A rank versus sector peers?: NVS quarterly SG&A is higher than 99.25% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

TTM SG&A

$158.17B$6.96B-4.22%

September 30, 2026

Summary

Current Value: As of today, NVS TTM SG&A is $158.17B, down -4.22% on September 30, 2026
Historical Performance: NVS TTM SG&A is up +1086.19% year-over-year, up +1190.53% over the past 3 years
All-Time High Comparison: NVS TTM SG&A is currently -49.89% below its historical high of $315.64B set on an earlier date
3-Year Low Comparison: NVS TTM SG&A is at its 3-year low
Sector Comparison: NVS TTM SG&A is higher than 99.18% of companies in Healthcare sector

Performance

NVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Sep 30, 26	$158.17B	+1104.1%	+1086.2%	+1190.5%	+966.9%
Annual SG&A	Dec 31, 25	$0.00	–	-100.0%	-100.0%	-100.0%
Quarterly SG&A	Sep 30, 26	$3.06B	-5.5%	-7.2%	-0.9%	-15.3%
Price	Nov 6, 26	$162.55	+5.4%	+28.4%	+73.9%	+94.3%
TTM Operating Profit	Sep 30, 26	$16.87B	+4.1%	-2.4%	+35.0%	+48.0%
TTM D&A	Sep 30, 26	$7.76B	+37.3%	+43.0%	-8.9%	+58.8%
TTM Revenue	Sep 30, 26	$55.35B	+1.0%	+1.7%	+23.9%	+8.1%

TTM SG&A Highs

NVS TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	$171.44B	N/A	-7.7%
3Y	$217.64B	N/A	-27.3%
5Y	$264.41B	N/A	-40.2%
All	$315.64B	N/A	-49.9%

TTM SG&A Lows

NVS TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	$158.17B	N/A	at low
3Y	$158.17B	N/A	at low
5Y	$158.17B	N/A	at low
All	$23.86B	N/A	+562.9%

TTM SG&A History

Month	Value	Change
Sep 2026	$12.90B	-1.8%
Jun 2026	$13.14B	-1.9%
Mar 2026	$13.39B	+0.7%
Dec 2025	$13.30B	-0.3%
Sep 2025	$13.33B	+1.0%
Jun 2025	$13.20B	+3.2%
Mar 2025	$12.80B	+1.8%
Dec 2024	$12.58B	+0.3%
Sep 2024	$12.54B	+0.6%
Jun 2024	$12.47B	0.0%
Mar 2024	$12.47B	-0.4%
Dec 2023	$12.52B	+2.1%
Sep 2023	$12.26B	+1.3%
Jun 2023	$12.10B	-3.9%
Mar 2023	$12.59B	-4.7%
Dec 2022	$13.21B	-5.7%
Sep 2022	$14.01B	-4.6%
Jun 2022	$14.70B	-1.2%
Mar 2022	$14.87B	-0.1%
Dec 2021	$14.89B	+0.4%
Sep 2021	$14.83B	+1.4%
Jun 2021	$14.63B	+2.7%
Mar 2021	$14.24B	+0.3%
Dec 2020	$14.20B	+0.1%
Sep 2020	$14.18B	-0.9%
Jun 2020	$14.31B	-1.5%
Mar 2020	$14.53B	+1.1%
Dec 2019	$14.37B	+1.6%
Sep 2019	$14.14B	+2.1%
Jun 2019	$13.85B	+0.7%
Mar 2019	$13.76B	+0.3%
Dec 2018	$13.72B	-2.6%
Sep 2018	$14.08B	-2.9%
Jun 2018	$14.50B	-2.1%
Mar 2018	$14.81B	-1.3%
Dec 2017	$15.00B	+1.4%
Sep 2017	$14.79B	+1.9%
Jun 2017	$14.52B	+1.1%
Mar 2017	$14.36B	+1.2%
Dec 2016	$14.19B	-0.3%
Sep 2016	$14.24B	-0.4%
Jun 2016	$14.30B	+0.2%
Mar 2016	$14.27B	+0.2%
Dec 2015	$14.25B	-0.6%
Sep 2015	$14.33B	-0.7%
Jun 2015	$14.43B	-1.9%
Mar 2015	$14.71B	-6.7%
Dec 2014	$15.76B	-1.1%
Sep 2014	$15.94B	-0.7%
Jun 2014	$16.05B	+0.7%
Mar 2014	$15.93B	+0.6%
Dec 2013	$15.84B	-3.0%
Sep 2013	$16.34B	-1.6%

Month	Value	Change
Jun 2013	$16.60B	-2.2%
Mar 2013	$16.96B	+1.5%
Dec 2012	$16.72B	+0.1%
Sep 2012	$16.70B	-4.6%
Jun 2012	$17.51B	-4.6%
Mar 2012	$18.36B	-2.6%
Dec 2011	$18.84B	-2.4%
Sep 2011	$19.30B	+5.1%
Jun 2011	$18.36B	+8.8%
Mar 2011	$16.88B	+5.6%
Dec 2010	$15.99B	+4.3%
Sep 2010	$15.32B	+2.8%
Jun 2010	$14.90B	-0.1%
Mar 2010	$14.91B	+2.5%
Dec 2009	$14.55B	+5.3%
Sep 2009	$13.82B	-0.7%
Jun 2009	$13.92B	-1.0%
Mar 2009	$14.06B	-0.1%
Dec 2008	$14.07B	+0.0%
Sep 2008	$14.06B	+2.1%
Jun 2008	$13.77B	+2.7%
Mar 2008	$13.42B	+0.6%
Dec 2007	$13.34B	+1.4%
Sep 2007	$13.16B	-5.1%
Jun 2007	$13.86B	+2.9%
Mar 2007	$13.47B	+3.6%
Dec 2006	$13.01B	+36.8%
Sep 2006	$9.51B	+69.0%
Jun 2006	$5.63B	+108.5%
Mar 2006	$2.70B	>+9,900.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	-100.0%
Mar 2001	$1.65B	0.0%
Dec 2000	$1.65B	0.0%
Jun 2000	$1.65B	-

FAQ

What is the current TTM SG&A of NVS?: As of today, NVS TTM SG&A is $158.17B
What is NVS TTM SG&A most recent change?: NVS TTM SG&A was down -4.22% on September 30, 2026
What is 1-year change in NVS TTM SG&A?: NVS TTM SG&A is up +1086.19% year-over-year
How does NVS TTM SG&A rank versus sector peers?: NVS TTM SG&A is higher than 99.18% of companies in Healthcare sector
When is NVS next earnings release?: The next earnings release for NVS is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Data Sources & References

NVS Official Website www.novartis.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs